Nanozymes for Catalytic Cancer Immunotherapy
Source abstract
Abstract
Nanozymes are nanoparticles with enzyme-mimicking properties. With the intrinsic catalytic properties, nanozymes are endowed with merits to modulate the immunosuppression of tumor immune microenvironment (TIME), mainly through altering reactive oxygen and nitrogen species (ROS/RNS) level. Besides redox imbalance, nanozymes can modulate other features of TIME, such as hypoxia. Modulations of TIME enabled by nanozymes can improve the effectiveness and efficiency of cancer therapies, especially immunotherapy. Two types of nanozymes, metal/metal oxide nanozymes and deoxyribozymes (DNAzymes) are currently investigated in cancer immunotherapy. They either act as standalone therapeutics or synergize with other therapeutic strategies to enhance antitumor effects. This Review summarizes the common nanozymes and their enzymatic properties, their interactions with TIME, and recent achievements of using nanozymes in cancer immunotherapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, Texas A&M University, 101 Bizzell Street, College Station, Texas 77843, United States
Department of Mechanical Engineering, Texas Tech University, 2500 Broadway, Lubbock, Texas 79409, United States
Department of Industrial & Systems Engineering, Texas A&M University, 101 Bizzell Street, College Station, Texas 77843, United States
References (100+)
Show source-provided references
1. 10.1172/JCI3140510.1172/JCI31405 ↗
2. 10.1016/j.immuni.2013.07.01210.1016/j.immuni.2013.07.012 ↗
3. Gedye, C. Principles of cancer immunotherapy. https://wiki.cancer.org.au/oncologyformedicalstudents/Principles_of_cancer_immunotherapy.
4. 10.1016/B978-0-12-407190-2.00007-110.1016/B978-0-12-407190-2.00007-1 ↗
5. 10.1186/ar241410.1186/ar2414 ↗
6. 10.1056/NEJMp151007910.1056/NEJMp1510079 ↗
7. 10.1001/jamanetworkopen.2019.253510.1001/jamanetworkopen.2019.2535 ↗
8. 10.1200/EDBK_24083710.1200/EDBK_240837 ↗
9. Balkwill F. R. · 201210.1242/jcs.116392 ↗
10. 10.1073/pnas.150851611210.1073/pnas.1508516112 ↗
11. Kalinski P. · 2017 · 110.1007/978-3-319-67577-0 ↗
12. 10.3389/fimmu.2018.0159110.3389/fimmu.2018.01591 ↗
13. 10.4161/onci.2205810.4161/onci.22058 ↗
14. 10.1021/acs.bioconjchem.7b0071910.1021/acs.bioconjchem.7b00719 ↗
15. 10.1073/pnas.160806911310.1073/pnas.1608069113 ↗
16. 10.1158/0008-5472.CAN-13-111710.1158/0008-5472.CAN-13-1117 ↗
17. 10.4049/jimmunol.181.12.838210.4049/jimmunol.181.12.8382 ↗
18. 10.1021/acs.accounts.9b0014010.1021/acs.accounts.9b00140 ↗
19. Davis M. E. · 2010 · 239
20. 10.1002/anie.20190972910.1002/anie.201909729 ↗
21. 10.1038/nnano.2007.26010.1038/nnano.2007.260 ↗
22. Yadav A. · Res. Environ. Life Sci. · 2016 · 9 · 1328
23. 10.1186/s12937-016-0186-510.1186/s12937-016-0186-5 ↗
24. 10.1021/acscatal.6b0347210.1021/acscatal.6b03472 ↗
25. 10.1002/ejic.20150123710.1002/ejic.201501237 ↗
26. 10.1039/c3cs35486e10.1039/c3cs35486e ↗
27. 10.1021/acs.chemrev.8b0067210.1021/acs.chemrev.8b00672 ↗
28. 10.1039/C8CS00457A10.1039/C8CS00457A ↗
29. 10.3389/fchem.2019.0004610.3389/fchem.2019.00046 ↗
30. 10.1002/smtd.20170031910.1002/smtd.201700319 ↗
31. 10.7150/thno.1773610.7150/thno.17736 ↗
32. 10.1002/chem.20180077010.1002/chem.201800770 ↗
33. 10.1039/C8NR00325D10.1039/C8NR00325D ↗
34. 10.1063/1.206187310.1063/1.2061873 ↗
35. 10.1016/j.biomaterials.2011.05.07310.1016/j.biomaterials.2011.05.073 ↗
36. 10.1039/c3cc40622a10.1039/c3cc40622a ↗
37. 10.1039/C4CC06855F10.1039/C4CC06855F ↗
38. 10.1002/9780470048672.wecb40610.1002/9780470048672.wecb406 ↗
39. 10.1158/0008-5472.CAN-18-247410.1158/0008-5472.CAN-18-2474 ↗
40. 10.1073/pnas.94.9.426210.1073/pnas.94.9.4262 ↗
41. 10.1039/C9CC06782E10.1039/C9CC06782E ↗
42. 10.1002/anie.20181399410.1002/anie.201813994 ↗
43. 10.1002/ange.20190564510.1002/ange.201905645 ↗
44. 10.1002/smll.20190148510.1002/smll.201901485 ↗
45. 10.1126/sciadv.aav549010.1126/sciadv.aav5490 ↗
46. 10.1021/acsnano.9b0045710.1021/acsnano.9b00457 ↗
47. 10.1177/153473541986235210.1177/1534735419862352 ↗
48. 10.1158/0008-5472.CAN-18-396210.1158/0008-5472.CAN-18-3962 ↗
49. 10.1016/j.lfs.2018.03.04410.1016/j.lfs.2018.03.044 ↗
50. 10.3390/biom502047210.3390/biom5020472 ↗
51. 10.1177/117727191875539110.1177/1177271918755391 ↗
52. 10.1038/nri250610.1038/nri2506 ↗
53. 10.1038/s41416-018-0333-110.1038/s41416-018-0333-1 ↗
54. 10.1073/pnas.181947311610.1073/pnas.1819473116 ↗
55. 10.1038/ni.386810.1038/ni.3868 ↗
56. 10.1155/2016/158096710.1155/2016/1580967 ↗
57. 10.1038/nm160910.1038/nm1609 ↗
58. 10.1002/eji.183026062010.1002/eji.1830260620 ↗
59. 10.1073/pnas.93.23.1311910.1073/pnas.93.23.13119 ↗
60. Schmielau J. · Cancer Res. · 2001 · 61 · 4756
61. 10.4049/jimmunol.172.2.98910.4049/jimmunol.172.2.989 ↗
62. 10.1073/pnas.101201610710.1073/pnas.1012016107 ↗
63. Brito C. · J. Immunol. · 1999 · 162 · 335610.4049/jimmunol.162.6.3356 ↗
64. 10.1084/jem.2010195610.1084/jem.20101956 ↗
65. 10.1002/eji.183026062010.1002/eji.1830260620 ↗
66. 10.1021/acs.nanolett.9b0133310.1021/acs.nanolett.9b01333 ↗
67. 10.1021/acsnano.8b0804510.1021/acsnano.8b08045 ↗
68. 10.1039/C9NR03060C10.1039/C9NR03060C ↗
69. 10.1002/adma.20190189310.1002/adma.201901893 ↗
70. 10.1021/acsnano.8b0099910.1021/acsnano.8b00999 ↗
71. 10.1021/nn405773r10.1021/nn405773r ↗
72. 10.1002/0470028637.met26210.1002/0470028637.met262 ↗
73. 10.1038/s41467-017-01050-010.1038/s41467-017-01050-0 ↗
74. 10.1007/s40820-019-0305-x10.1007/s40820-019-0305-x ↗
75. 10.1002/adfm.20160067610.1002/adfm.201600676 ↗
76. 10.1039/C7SC05476A10.1039/C7SC05476A ↗
77. 10.1158/0008-5472.CAN-15-347510.1158/0008-5472.CAN-15-3475 ↗
78. 10.3390/md1612051010.3390/md16120510 ↗
79. 10.1039/C9SC00747D10.1039/C9SC00747D ↗
80. 10.1002/anie.20190475110.1002/anie.201904751 ↗
81. 10.1039/C8RA05487H10.1039/C8RA05487H ↗
82. 10.1038/s41467-018-03903-810.1038/s41467-018-03903-8 ↗
83. 10.1002/advs.20180173310.1002/advs.201801733 ↗
84. 10.1021/acs.analchem.9b0165510.1021/acs.analchem.9b01655 ↗
85. 10.1038/s41467-018-03903-810.1038/s41467-018-03903-8 ↗
86. 10.1158/0008-5472.CAN-14-259810.1158/0008-5472.CAN-14-2598 ↗
87. 10.1159/00046442910.1159/000464429 ↗
88. 10.3389/fmolb.2019.0006010.3389/fmolb.2019.00060 ↗
89. 10.1093/intimm/dxy03810.1093/intimm/dxy038 ↗
90. 10.1126/scitranslmed.aaa126010.1126/scitranslmed.aaa1260 ↗
91. Qian X. · American Journal of Cancer Research · 2019 · 9 · 529
92. 10.1002/adfm.20140451110.1002/adfm.201404511 ↗
93. 10.1038/s41467-018-05798-x10.1038/s41467-018-05798-x ↗
94. 10.1158/0008-5472.CAN-18-247410.1158/0008-5472.CAN-18-2474 ↗
95. 10.1089/1043034995001657310.1089/10430349950016573 ↗
96. 10.1038/sj.thj.620053510.1038/sj.thj.6200535 ↗
97. 10.1021/acsami.8b2244410.1021/acsami.8b22444 ↗
98. 10.7314/APJCP.2012.13.12.623310.7314/APJCP.2012.13.12.6233 ↗
99. 10.2119/molmed.2013.0009010.2119/molmed.2013.00090 ↗
100. 10.1038/nm90510.1038/nm905 ↗